HNSCC cell lines with amplification and high-level expression of ANO1 showed enhanced sensitivity to gefitinib, and co-inhibition of EGFR and ANO1 had an additive suppressive effect on cellular proliferation. Here, ANO1 is linked to head and neck squamous cell carcinoma.